Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mammary Neoplasms, Human”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT05746897
What this trial is testing

A First-in-human, Phase I, Open-label, Multicenter Study of NM1F(Anti-PVRIG) in Patients With Advanced Solid Tumors

Who this might be right for
Ovarian CancerMelanomaTriple Negative Breast Cancer+1 more
Hefei TG ImmunoPharma Co., Ltd. 38
Early research (Phase 1)Looking for participantsNCT07137416
What this trial is testing

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Invasive Breast Carcinoma+13 more
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT02222922
What this trial is testing

PF-06647020 For Adult Patients With Advanced Solid Tumors

Who this might be right for
Neoplasms
Pfizer 138
Early research (Phase 1)Looking for participantsNCT06586957
What this trial is testing

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorAdvanced Solid TumorSolid Tumor, Adult+25 more
NiKang Therapeutics, Inc. 150
Early research (Phase 1)UnknownNCT04450732
What this trial is testing

Safety of GQ1001 in Adult Patients With HER2-Positive Advanced Solid Tumors

Who this might be right for
HER2-positive Breast CancerHER2-positive Biliary Tract CancerHER2-Positive Salivary Gland Carcinomas+1 more
GeneQuantum Healthcare (Suzhou) Co., Ltd. 96
Early research (Phase 1)WithdrawnNCT02035085
What this trial is testing

19F Hot Spot MRI of Human Adipose-derived Stem Cells for Breast Reconstruction

Who this might be right for
Breast Cancer
Johns Hopkins University
Not applicableStudy completedNCT02535026
What this trial is testing

An Observational Study on Human Epidermal Growth Factor Receptor (HER) 2 Status of Breast Invasive Carcinoma in Latin American Participants

Who this might be right for
Breast Cancer
Hoffmann-La Roche 580
Testing effectiveness (Phase 2)Active Not RecruitingNCT03650894
What this trial is testing

Nivolumab, Ipilimumab, and Bicalutamide in Human Epidermal Growth Factor (HER) 2 Negative Breast Cancer Patients

Who this might be right for
Breast Neoplasm FemaleBreast CancerBreast Carcinoma+1 more
Providence Health & Services 30
Early research (Phase 1)Looking for participantsNCT07081555
What this trial is testing

A First-in-Human Phase 1 Safety and Biodistribution of [177Lu]Lu-ABY-271 in Subjects With HER2-positive Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerHER2 + Breast Cancer
Affibody 21
Not applicableStudy completedNCT02449993
What this trial is testing

Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant Therapy

Who this might be right for
Breast Cancer
BioNTech Diagnostics GmbH 101
Not applicableNot Yet RecruitingNCT07060599
What this trial is testing

Human-AI Collaborative INSIGHT Diagnostic Workflow for in Breast Cancer With Extensive Intraductal Component

Who this might be right for
Artificial Intelligence (AI) in Diagnosis
Sun Yat-sen University 480
Not applicableStudy completedNCT00568438
What this trial is testing

Immunohistochemical & Immunoblot Analysis of NIS (Na+/I-Symporter) in Archival & Frozen Tissue Sample

Who this might be right for
Breast CancerStomach NeoplasmsSalivary Gland Neoplasms+1 more
Stanford University 169
Early research (Phase 1)Study completedNCT04134884
What this trial is testing

Study of ASTX727 Plus Talazoparib in Patients With Triple Negative or Hormone Resistant/HER2-negative Metastatic Breast Cancer

Who this might be right for
Metastatic Breast CancerTriple Negative Breast CancerHormone Receptor Positive Tumor
Kathy Miller 34
Large-scale testing (Phase 3)Active Not RecruitingNCT04862663
What this trial is testing

Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)

Who this might be right for
Locally Advanced (Inoperable) or Metastatic Breast Cancer
AstraZeneca 893
Early research (Phase 1)Study completedNCT01730118
What this trial is testing

Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing

Who this might be right for
Breast NeoplasmsBreast CancerAdenocarcinomas+1 more
National Cancer Institute (NCI) 33
Early research (Phase 1)Looking for participantsNCT05556473
What this trial is testing

F-Tryptophan PET/CT in Human Cancers

Who this might be right for
Intracranial GliomaMetastatic Brain TumorBreast Cancer+2 more
Barbara Ann Karmanos Cancer Institute 24
Large-scale testing (Phase 3)Study completedNCT03901339
What this trial is testing

Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Gilead Sciences 543
Early research (Phase 1)Study completedNCT05923177
What this trial is testing

Molecular Imaging of HER2 Expression in Breast Cancer Using [123I] I-(HE)3-G3

Who this might be right for
Primary Breast Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 10
Early research (Phase 1)Looking for participantsNCT06666270
What this trial is testing

Study of SYN818 for the Treatment of Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid CancerMetastatic Solid TumorOvarian Cancer+4 more
Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd 30
Early research (Phase 1)Study completedNCT04277338
What this trial is testing

Molecular Imaging of HER2 Expression in Breast Cancer Using 99mTc-HE3-G3

Who this might be right for
Primary Breast Cancer
Tomsk National Research Medical Center of the Russian Academy of Sciences 30
Next Page